INTRAVITREAL METHOTREXATE INJECTION FOR THE TREATMENT AND PREVENTION OF PROLIFERATIVE VITREORETINOPATHY
Serial intravitreal MTX injection was associated with 90% single operation retinal reattachment rate in the setting of retinal detachment with proliferative vitreoretinopathy or retinal detachment at high risk of proliferative vitreoretinopathy.
Authors
- Orlando G. Gonzalez Martinez (ORCID: https://orcid.org/0000-0003-1326-2782)
- Marco A. Zarbin (ORCID: https://orcid.org/0000-0002-7811-7132)
- Neelakshi Bhagat (ORCID: https://orcid.org/0000-0003-2187-3145)
- Patrick J. Hughes
Institutions
- Rutgers, The State University of New Jersey (US)
- Rutgers New Jersey Medical School (US)
Publication Details
- Journal
- Retina
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1097/iae.0000000000004181
- Citations
- 7
- Primary Topic
- Retinal and Macular Surgery
- Type
- article
- Field-Weighted Citation Impact
- 2.83